Promega Unveils GloMax® Galaxy Bioluminescence Imager for Illuminating Protein Dynamics in Real Time
New microscope enables researchers to use NanoLuc® Luciferase to observe protein dynamics and cellular physiology in live cells, in real time Bioluminescence imaging allows for use of a single ...
MADISON, Wis.–(BUSINESS WIRE)–#CSR–Promega Corporation, a global biotechnology manufacturer, today announced publication of its annual Corporate Responsibility Report of sustainable practices and ...
Promega authorizes UBC RNA & Formulation Core to distribute NanoLuc-encoding mRNA, expanding researcher access for LNP and ...
The Spectrum Compact CE System is an integrated and efficient instrument that brings you the independence to perform Sanger sequencing and fragment analysis in your laboratory, under your control, and ...
Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate ...
Hosted on MSN
Promega expands forensic portfolio with distribution agreement for NimaGen’s IDseek® MPS library prep kits
Forensic casework laboratories will now have access to NimaGen’s IDseek ® massively parallel sequencing (MPS) kit portfolio through Promega Corporation, following a distribution agreement announced ...
Promega has scored an FDA green light for its microsatellite instability testing technology as a companion diagnostic for Merck and Eisai’s Keytruda-Lenvima combination for patients with advanced ...
Promega First to Achieve Third-Party Certification of Published ISO 18385 Manufacturing Standard to Minimize Risk of Human DNA Contamination in Forensic Products Promega Corporation has become the ...
FITCHBURG, Wis. (AP) — Promega Corp. and its founder are firing back at shareholders who sued the Wisconsin biotechnology company in 2016 for shareholder oppression. The lawsuit filed by shareholders ...
TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery Promega Corporation is launching a new live-cell target engagement platform that could close a ...
Authorization expands academic and industry researcher access for LNP delivery optimization, mRNA vaccine development and gene therapy research A new agreement between Promega Corporation and the RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results